Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne M Butler

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Erectile function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Brachytherapy|June 9, 2015
Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trialsGregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Urology|January 26, 2005
Influence of body mass index on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trialGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Dysuria after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Erectile function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Brachytherapy|June 9, 2015
Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trialsGregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Urology|January 26, 2005
Influence of body mass index on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trialGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Dysuria after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Pageof 17